| Literature DB >> 28348875 |
Lauren A Cowley1, Timothy J Dallman1, Stephen Fitzgerald2, Neil Irvine3, Paul J Rooney4, Sean P McAteer2, Martin Day1, Neil T Perry1, James L Bono5, Claire Jenkins1, David L Gally2.
Abstract
Shiga toxin-producing Escherichia coli (STEC) O157:H7 is a public health threat and outbreaks occur worldwide. Here, we investigate genomic differences between related STEC O157:H7 that caused two outbreaks, eight weeks apart, at the same restaurant. Short-read genome sequencing divided the outbreak strains into two sub-clusters separated by only three single-nucleotide polymorphisms in the core genome while traditional typing identified them as separate phage types, PT8 and PT54. Isolates did not cluster with local strains but with those associated with foreign travel to the Middle East/North Africa. Combined long-read sequencing approaches and optical mapping revealed that the two outbreak strains had undergone significant microevolution in the accessory genome with prophage gain, loss and recombination. In addition, the PT54 sub-type had acquired a 240 kbp multi-drug resistance (MDR) IncHI2 plasmid responsible for the phage type switch. A PT54 isolate had a general fitness advantage over a PT8 isolate in rich medium, including an increased capacity to use specific amino acids and dipeptides as a nitrogen source. The second outbreak was considerably larger and there were multiple secondary cases indicative of effective human-to-human transmission. We speculate that MDR plasmid acquisition and prophage changes have adapted the PT54 strain for human infection and transmission. Our study shows the added insights provided by combining whole-genome sequencing approaches for outbreak investigations.Entities:
Keywords: Bioinformatics; Escherichia coli; Evolution; Prophage; Recombination
Mesh:
Year: 2016 PMID: 28348875 PMCID: PMC5320650 DOI: 10.1099/mgen.0.000084
Source DB: PubMed Journal: Microb Genom ISSN: 2057-5858
Fig. 1.Maximum-likelihood phylogenetic tree of STEC O157 strains selected for various PTs in PHE database associated with domestically acquired infection and travel-related cases. SNPs called on core genome via a mapping technique against the reference strain Sakai. Outbreak strains are indicated in blue and local background strains in the region where the outbreak occurred are in red.
Fig. 2.Maximum-likelihood phylogenetic tree of outbreak strains and most closely related strains in the PHE database that are associated with foreign travel to Egypt and Israel. The blue branches represent strains that are associated with travel to Egypt and Israel, the pink branches represent the original PT8 outbreak and the red branches represent the later PT54 outbreak.
Fig. 3.Schematic diagram representing accessory genome variation between the two long-read-sequenced outbreak isolates (180-PT54 and 644-PT8). Blue rectangles represent shared prophage regions, the orange rectangle represents a unique 180-PT54 prophage region and green rectangles represent unique 644-PT8 prophage regions. Orange triangles represent locations and number of unique genes for 180-PT54. The inverted repeat region is indicated by a blue line above the repeated prophage blocks. The unique plasmid in the PT54 outbreak is represented by the orange circle. Those changes that have been confirmed to be representative of all the other members of that PT sub-cluster by Roary analysis have an asterisk next to them.
Table listing the positions and base changes of all the SNPs found between the PT8 strain and the PT54 strain in a whole-genome alignment using the program NUCMER
The SNPs identified by the previous phylogenetic analysis using Illumina data are highlighted in bold and italicized type, the third SNP identified by the phylogenetic analysis is within a repeat region so was excluded as ambiguous alignment by the program NUCMER. All other identified SNPSs, not in bold, are part of the mobilome.
| PT54 position | PT54 base | PT8 base | PT8 position |
|---|---|---|---|
| 1975308 | G | C | 1974495 |
| 2681706 | C | A | 3282472 |
| 2681715 | T | C | 3282463 |
| 2681722 | T | C | 3282456 |
| 2681730 | T | G | 3282448 |
| 2681757 | T | G | 3282421 |
| 2681766 | G | T | 3282412 |
| 2681775 | A | G | 3282403 |
| 2681784 | C | T | 3282394 |
| 2681788 | G | A | 3282390 |
| 2681796 | T | C | 3282382 |
| 2681823 | G | A | 3282355 |
| 2681833 | G | A | 3282345 |
| 2681835 | C | T | 3282343 |
| 2681844 | A | G | 3282334 |
| 2681847 | G | A | 3282331 |
| 2681865 | G | A | 3282313 |
| 2681973 | C | T | 3282205 |
| 2681976 | C | G | 3282202 |
| 2681977 | T | C | 3282201 |
| 2681979 | T | A | 3282199 |
| 2681981 | A | C | 3282197 |
| 2681982 | C | A | 3282196 |
| 2681985 | C | A | 3282193 |
| 3048043 | C | A | 3242600 |
| 3048059 | C | A | 3242616 |
| 3048069 | G | A | 3242626 |
Fig. 4.BRIG plot of the approximately 240 kbp IncHI2 plasmid found in 180-PT54 as the central reference showing genomic similarity between it and other IncHI2 plasmids found in Genbank from various species of bacteria. Annotations are shown in red on the outermost ring. The darker the colour the greater the level of genomic similarity between the 180-PT54 IncHI2 plasmid and the plasmid found in a different organism. The plasmids are indicated by the colours labelled vertically at the right hand side of the figure.
Table describing the results of the acid-resistance assays performed on strains 644-PT8 and 180-PT54 to assess their biological fitness
| Adaptation medium* | Challenge medium (pH2.5) | Percentage survival† | |
|---|---|---|---|
| PT54 | PT8 | ||
| LB pH8 | EG | 0.811582004 | 0.187176 |
| LB pH 5.5 | EG | 4.09726344 | 38.78565 |
| LBG | EG | 14.77276286 | 7.230324 |
| EG+Glu | 21.71965529 | 52.69993 | |
| EG+Arg | 37.2807674 | 70.11365 | |
*Strains were adapted by overnight culturing in either LB pH 5.5 or LBG before diluting 1:1000 in EG pH 2.5 or supplemented EG. †The percentage survival was determined after 4 h of acid challenge. The mean percentage survival of six replicates (n=6) is shown for EG challenge and three replicates (n=3) for EG supplemented with either glutamate (1.5 mM) or arginine (0.6 mM).